2026-06-14T03:39:45Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/142542024-11-28T14:25:56Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_14556com_20.500.12105_2337com_20.500.12105_2336col_20.500.12105_19609col_20.500.12105_14558

00925njm 22002777a 4500 dc Cañada-Garcia, Javier Enrique author Perez-Vazquez, Maria author Oteo-Iglesias, Jesus author 2021-09 There is an urgent need to control the clinical and public health impact that antibiotic resistance (AR) causes worldwide. Any measure for its control must be based on an up-to-date and comprehensive knowledge of the situation. However, it is difficult to determine the current dimension of AR because a large part of the available information is based on heterogeneous, insufficiently unified and retrospective data. The integration of genomic information in the surveillance of AR is another important factor for improvement. The Spanish Network of Laboratories for the Surveillance of Resistant Microorganisms (RedLabRA) is a structured network of interconnected microbiology laboratories developed within the Spanish National Plan against Antibiotic Resistance. Its main objective is to support the diagnosis of resistance to antibiotics, integrating molecular characterization in the surveillance. Rev Esp Quimioter. 2021 Sep;34 Suppl 1:12-14. 10.37201/req/s01.03.2021 1988-9518 Revista española de quimioterapia: publicacioón oficial de la Sociedad Española de Quimioterapia 34598415 http://hdl.handle.net/20.500.12105/14254 Antibiotic resistance Antibiotic resistance mechanisms RedLabRA Surveillance RedLabRA; a Spanish Network of Microbiology Laboratories for the Surveillance of Antibiotic Resistant Microorganisms